Club Natació Poble Nou
Barcelona, Spain
NCT Number: NCT07041853
This double-blind, randomised, placebo-controlled trial will examine the effects of 42-day root extract ashwagandha (KSM-66) supplementation on recovery and muscle strength in male and female rugby and water polo players. Participants will receive either 600 mg of ashwagandha or a placebo daily. Outcomes include hormonal stress markers, perceived exertion, wellness, muscle soreness and strength and performance metrics (grip strength, jump tests, 1RM lifts, Bronco test).
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Barcelona, Spain
This double-blind, randomised, placebo-controlled trial aims to investigate the effects of ashwagandha (ASH) supplementation on recovery and muscle strength in male and female rugby and water polo players. Participants will supplement either KSM-66 ashwagandha (600 mg, standardised to 5% withanolides) or a placebo once daily for 42 days. The study will evaluate outcomes related to hormonal stress markers, perceived exertion, wellness, muscle soreness, and physical performance.
Primary biomarkers include cortisol, DHEA-S, testosterone, melatonin, alpha-amylase, and cortisone, assessed through saliva samples. Subjective measures will include the Borg Rate of Perceived Exertion Scale and the Hooper Index for sleep quality, stress, fatigue, and delayed onset muscle soreness (DOMS). Physical performance will be assessed using grip strength (CAMRY dynamometer), vertical jump tests (countermovement jump, squat jump), broad jump, 1-repetition maximum (1RM) tests for deadlift, bench press, and pull-up, as well as the Bronco test. Supplement satisfaction will be evaluated via questionnaire.
Participants' dietary intake will be recorded using a self-tracking method (Snap-N-Send) and analysed using Nutritics software; food diaries will serve as covariates in the final analysis. The study will be conducted in partnership with CN Poble Nou, a professional sports club in Barcelona, Spain.
Ashwagandha use is increasingly common among athletes despite limited evidence on appropriate dosing and performance outcomes. This study will contribute to scientific understanding of its potential short-term benefits, particularly in high-contact sports where managing cortisol and recovery is critical.
All participants will provide informed consent, and ethical considerations focus on safety, data privacy, and the right to withdraw from the study at any time.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Root extract ashwagandha, KSM-66
Organic chickpea flour
Time frame: Baseline and final measurement at 6 weeks
Salivary cortisol
Time frame: Baseline and final measurement at 6 weeks
Hand grip strength in kilograms, CAMRY dynanometer
Time frame: Baseline and final measurement at 6 weeks
Salivary testosterone
Time frame: Baseline and final measurement at 6 weeks
Salivary melatonin
Time frame: Baseline and final measurement at 6 weeks
Salivary DHEA-s
Time frame: Baseline and final measurement at 6 weeks
Salivary alpha-amylase
Time frame: Baseline and final measurement at 6 weeks
Salivary cortisone
Time frame: Baseline and final measurement at 6 weeks
Aerobic fitness test in minutes and seconds
University Ramon Llull
Other
The Effects of KSM-66 Ashwagandha (Withania Somnifera) Supplementation on Recovery and Muscle Strength in Academy Athletes
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04676958
Behavior, Exercise
Glasgow, United Kingdom
View Trial DetailsNCT07676110
Agnosia, Anxiety Disorders
Fort Collins, Colorado, United States
View Trial DetailsNCT07728422
Muscle Damage, Oxidative Stress
Malatya, Turkey (Türkiye)
View Trial DetailsNCT07700576
Behavior, Behavioral Symptoms
Malatya, Turkey (Türkiye)
View Trial Details